Income Taxes	9 Months Ended
Sep. 30, 2017
Income Tax Disclosure [Abstract]
Income Taxes	NOTE L – INCOME TAXES The Company’s effective tax rate was 36% and 27% for the three months ended September 30, 2017 and 2016, respectively, and 34% and 27% for the nine months ended September 30, 2017 and 2016, respectively. The higher effective tax rate for the three months ended September 30, 2017, compared to the U.S. federal statutory tax rate of 35%, was primarily due to U.S permanent items, predominantly related to the repatriation of foreign earnings that are not permanently reinvested, offset by an increase in earnings in jurisdictions with tax rates lower than the U.S. federal statutory tax rate where such earnings are reinvested. The lower effective tax rate for the nine months ended September 30, 2017 compared to the U.S federal statutory tax rate of 35% was primarily due to an increase in earnings in jurisdictions with lower tax rates than the U.S. federal statutory rate where such earnings are permanently reinvested and offset by U.S. permanent items primarily related to the repatriation of foreign earnings that are not permanently reinvested. The higher tax rate for the three and nine months ended September 30, 2017, compared with the same periods for 2016, was primarily due to the repatriation of foreign earnings that are not permanently reinvested. As described in Note I, effective January 1, 2017, the Company adopted the new guidance (ASU 2016-09) and will record excess tax benefits or tax deficiencies from stock-based compensation in the Statements of Consolidated Income within the provision for income taxes rather than in the Consolidated Balance Sheets within Paid-in capital. The related financial statement impacts of adopting ASU 2016-09 have not been material to the Company’s Consolidated Financial Statements. The Company provides valuation allowances against deferred tax assets when it is more likely than not that a portion or all of its deferred tax assets will not be realized. During the nine months ended September 30, 2017, the Company recorded a $.2 million valuation allowance as a discrete item against a deferred tax asset resulting from a capital loss carry forward generated in 2016. During the period ended September 30, 2017, the Company did not record any unrecognized tax benefits and as of September 30, 2017, the Company has no unrecognized tax benefits. The Company does not anticipate any significant changes to its gross unrecognized tax benefits within the next twelve months.

NOTE L – INCOME TAXES

The Company’s effective tax rate was 36% and 27% for the three months ended September 30, 2017 and 2016, respectively, and 34% and 27% for the nine months ended September 30, 2017 and 2016, respectively. The higher effective tax rate for the three months ended September 30, 2017, compared to the U.S. federal statutory tax rate of 35%, was primarily due to U.S permanent items, predominantly related to the repatriation of foreign earnings that are not permanently reinvested, offset by an increase in earnings in jurisdictions with tax rates lower than the U.S. federal statutory tax rate where such earnings are reinvested. The lower effective tax rate for the nine months ended September 30, 2017 compared to the U.S federal statutory tax rate of 35% was primarily due to an increase in earnings in jurisdictions with lower tax rates than the U.S. federal statutory rate where such earnings are permanently reinvested and offset by U.S. permanent items primarily related to the repatriation of foreign earnings that are not permanently reinvested. The higher tax rate for the three and nine months ended September 30, 2017, compared with the same periods for 2016, was primarily due to the repatriation of foreign earnings that are not permanently reinvested.

As described in Note I, effective January 1, 2017, the Company adopted the new guidance (ASU 2016-09) and will record excess tax benefits or tax deficiencies from stock-based compensation in the Statements of Consolidated Income within the provision for income taxes rather than in the Consolidated Balance Sheets within Paid-in capital. The related financial statement impacts of adopting ASU 2016-09 have not been material to the Company’s Consolidated Financial Statements.

The Company provides valuation allowances against deferred tax assets when it is more likely than not that a portion or all of its deferred tax assets will not be realized. During the nine months ended September 30, 2017, the Company recorded a $.2 million valuation allowance as a discrete item against a deferred tax asset resulting from a capital loss carry forward generated in 2016.

During the period ended September 30, 2017, the Company did not record any unrecognized tax benefits and as of September 30, 2017, the Company has no unrecognized tax benefits. The Company does not anticipate any significant changes to its gross unrecognized tax benefits within the next twelve months.